Federal contractor · CLEVELAND, OH
ARTERIOCYTE, INC.
No contract obligations recorded for ARTERIOCYTE, INC. in FY2026. Since FY2017: $1.3M.
- Obligations · FY2026
- $0
- New awards
- 0
- Sole-source
- —
- Single offer
- —
- UEI
- P997X1C88B47
Spending by fiscal year
Obligations per federal fiscal year (October–September).
- 0FY2017
- 1.3MFY2018
- -0FY2019
- -14.3KFY2022
- -5.2KFY2024
Top buying agencies
Obligations in FY2026.
No contract obligations recorded for ARTERIOCYTE, INC. in FY2026.
What was bought · Where the work was performed
Obligations in FY2026.
What was bought
Where the work was performed
Integrity signals
Shares of the year's obligations, next to the country's.
Federal grants & assistance received
Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.
ARTERIOCYTE, INC. received $0 in federal assistance in FY2026, on 0 actions (0 new awards).
- Assistance · FY2026
- $0
- New awards
- 0
- Actions
- 0
- Since FY2021
- -$101K
Assistance by fiscal year
- 0FY2021
- -14.2KFY2022
- -86.8KFY2025
Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 7, 2026, loaded Oct 7, 2026 · FY2021–FY2025.
Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 7, 2026, loaded Oct 7, 2026.